Review



gnrh antagonists  (Serono)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Serono gnrh antagonists
    Gnrh Antagonists, supplied by Serono, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gnrh+antagonists/antagonist+gnrh/pm42165893-68-0-4
    Average 86 stars, based on 1 article reviews
    gnrh antagonists - by Bioz Stars, 2026-11
    86/100 stars

    Images

    Related Articles

    other:

    Article Title: Embryological and clinical predictors of implantation and live birth in 3000 single euploid embryo transfer cycles: a retrospective cohort study.
    Article Snippet: GnRH antagonists (Cetrotide ®, Merck-Serono, Switzerland; or Orgalutran ®, MSD, The Netherlands) were initiated when at least one follicle reached a diameter of ≥14 mm.

    Article Title: The Kisspeptin and Kisspeptin receptor in follicular microenvironment: is that really necessary for oocyte maturation and fertilisation?
    Article Snippet: The aim of this study was to determine whether Kisspeptin and Kisspeptin receptor in the follicular microenvironment is necessary for human oocyte maturation and fertilisation.. The cumulus cell (CC) and follicle fluids (FF) obtained from the first aspirated follicles (n1⁄4 52) from 32 patients were divided into three groups considering nuclear maturation and fertilisation results of oocytes: (1) Metaphase I or germinal vesicle stage oocytes (incomplete nuclear maturation, n1⁄4 10), (2) unfertilised metaphase II oocytes (incomplete cytoplasmic maturation, n1⁄4 16), and (3) fertilised metaphase II oocytes (completed nuclear-cytoplasmic maturation, n1⁄4 26).. The gene expression levels were assessed by RT-PCR.

    Recombinant:

    Article Title: Estrogen promotes luteolysis by redistributing prostaglandin F2α receptors within primate luteal cells
    Article Snippet: .. Recombinant human gonadotropins and GNRH antagonists were generously provided by Merck & Co., Whitehouse Station, NJ, USA and Serono Reproductive Biology Institute, Rockland, MA, USA. .. Novartis Pharma (Basel, Switzerland) generously provided the aromatase inhibitor letrozole.



    Similar Products

    gnrh antagonist relugolix  (MedChemExpress)
    94
    MedChemExpress gnrh antagonist relugolix
    Analysis of the expression differences of target genes between the control group and the experimental group. Note: The x -axis represents different groups. The control group was the normal culture group at 18 °C, and the experimental group was the <t>Relugolix-treated</t> group at 18 °C. ( A ) Expression detected by qRT-PCR; ( B ) Expression in the transcriptome. * indicates a significant difference in expression level in the experimental group compared with the control group ( p < 0.05), and ** indicates an extremely significant difference ( p < 0.01).
    Gnrh Antagonist Relugolix, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gnrh+antagonists/Relugolix/pmc13255659-62-10-16
    Average 94 stars, based on 1 article reviews
    gnrh antagonist relugolix - by Bioz Stars, 2026-11
    94/100 stars
    		  Buy from Supplier
    gnrh antagonists  (Serono)
    86
    Serono gnrh antagonists
    Analysis of the expression differences of target genes between the control group and the experimental group. Note: The x -axis represents different groups. The control group was the normal culture group at 18 °C, and the experimental group was the <t>Relugolix-treated</t> group at 18 °C. ( A ) Expression detected by qRT-PCR; ( B ) Expression in the transcriptome. * indicates a significant difference in expression level in the experimental group compared with the control group ( p < 0.05), and ** indicates an extremely significant difference ( p < 0.01).
    Gnrh Antagonists, supplied by Serono, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gnrh+antagonists/antagonist+gnrh/pm42165893-68-0-4
    Average 86 stars, based on 1 article reviews
    gnrh antagonists - by Bioz Stars, 2026-11
    86/100 stars
    		  Buy from Supplier
    gnrh antagonist  (Serono)
    86
    Serono gnrh antagonist
    Analysis of the expression differences of target genes between the control group and the experimental group. Note: The x -axis represents different groups. The control group was the normal culture group at 18 °C, and the experimental group was the <t>Relugolix-treated</t> group at 18 °C. ( A ) Expression detected by qRT-PCR; ( B ) Expression in the transcriptome. * indicates a significant difference in expression level in the experimental group compared with the control group ( p < 0.05), and ** indicates an extremely significant difference ( p < 0.01).
    Gnrh Antagonist, supplied by Serono, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gnrh+antagonists/cetrotide/pm42122247-77-1-4
    Average 86 stars, based on 1 article reviews
    gnrh antagonist - by Bioz Stars, 2026-11
    86/100 stars
    		  Buy from Supplier
    hormone gnrh antagonist regimen cetrorelix  (Serono)
    86
    Serono hormone gnrh antagonist regimen cetrorelix
    Analysis of the expression differences of target genes between the control group and the experimental group. Note: The x -axis represents different groups. The control group was the normal culture group at 18 °C, and the experimental group was the <t>Relugolix-treated</t> group at 18 °C. ( A ) Expression detected by qRT-PCR; ( B ) Expression in the transcriptome. * indicates a significant difference in expression level in the experimental group compared with the control group ( p < 0.05), and ** indicates an extremely significant difference ( p < 0.01).
    Hormone Gnrh Antagonist Regimen Cetrorelix, supplied by Serono, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gnrh+antagonists/antagonist+gnrh/pm41949741-27-10-17
    Average 86 stars, based on 1 article reviews
    hormone gnrh antagonist regimen cetrorelix - by Bioz Stars, 2026-11
    86/100 stars
    		  Buy from Supplier
    gnrh antagonist cetrorelix acetate  (Serono)
    86
    Serono gnrh antagonist cetrorelix acetate
    Analysis of the expression differences of target genes between the control group and the experimental group. Note: The x -axis represents different groups. The control group was the normal culture group at 18 °C, and the experimental group was the <t>Relugolix-treated</t> group at 18 °C. ( A ) Expression detected by qRT-PCR; ( B ) Expression in the transcriptome. * indicates a significant difference in expression level in the experimental group compared with the control group ( p < 0.05), and ** indicates an extremely significant difference ( p < 0.01).
    Gnrh Antagonist Cetrorelix Acetate, supplied by Serono, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gnrh+antagonists/antagonist+gnrh/pmc13113854-77-1-4
    Average 86 stars, based on 1 article reviews
    gnrh antagonist cetrorelix acetate - by Bioz Stars, 2026-11
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Analysis of the expression differences of target genes between the control group and the experimental group. Note: The x -axis represents different groups. The control group was the normal culture group at 18 °C, and the experimental group was the Relugolix-treated group at 18 °C. ( A ) Expression detected by qRT-PCR; ( B ) Expression in the transcriptome. * indicates a significant difference in expression level in the experimental group compared with the control group ( p < 0.05), and ** indicates an extremely significant difference ( p < 0.01).

    Journal: Biology

    Article Title: GnRH Regulates Sex Differentiation in Sebastes schlegelii Through TGF-β/MAPK Signaling Pathways

    doi: 10.3390/biology15110857

    Figure Lengend Snippet: Analysis of the expression differences of target genes between the control group and the experimental group. Note: The x -axis represents different groups. The control group was the normal culture group at 18 °C, and the experimental group was the Relugolix-treated group at 18 °C. ( A ) Expression detected by qRT-PCR; ( B ) Expression in the transcriptome. * indicates a significant difference in expression level in the experimental group compared with the control group ( p < 0.05), and ** indicates an extremely significant difference ( p < 0.01).

    Article Snippet: The experimental group was fed a diet supplemented with the GnRH antagonist Relugolix (Cat. No. HY-16474; MedChemExpress LLC, Monmouth Junction, NJ, USA) at a dosage of 3 mg/kg body weight, as recommended by the manufacturer’s instructions. qPCR was used to detect the expression of downstream genes to verify the treatment effect of Relugolix.

    Techniques: Expressing, Control, Quantitative RT-PCR

    Hypothetical model of GnRH receptor antagonism-induced masculinization in genetic female S. schlegelii based on transcriptomic data. The proposed relationships are correlative, not causal, and require functional validation.

    Journal: Biology

    Article Title: GnRH Regulates Sex Differentiation in Sebastes schlegelii Through TGF-β/MAPK Signaling Pathways

    doi: 10.3390/biology15110857

    Figure Lengend Snippet: Hypothetical model of GnRH receptor antagonism-induced masculinization in genetic female S. schlegelii based on transcriptomic data. The proposed relationships are correlative, not causal, and require functional validation.

    Article Snippet: The experimental group was fed a diet supplemented with the GnRH antagonist Relugolix (Cat. No. HY-16474; MedChemExpress LLC, Monmouth Junction, NJ, USA) at a dosage of 3 mg/kg body weight, as recommended by the manufacturer’s instructions. qPCR was used to detect the expression of downstream genes to verify the treatment effect of Relugolix.

    Techniques: Functional Assay, Biomarker Discovery